Logo image of KRMD

KORU MEDICAL SYSTEMS INC (KRMD) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:KRMD - US7599101026 - Common Stock

6.22 USD
+0.15 (+2.47%)
Last: 12/23/2025, 11:54:05 AM
Fundamental Rating

3

KRMD gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 184 industry peers in the Health Care Equipment & Supplies industry. The financial health of KRMD is average, but there are quite some concerns on its profitability. KRMD is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

KRMD had negative earnings in the past year.
In the past year KRMD had a positive cash flow from operations.
In the past 5 years KRMD always reported negative net income.
KRMD had a negative operating cash flow in each of the past 5 years.
KRMD Yearly Net Income VS EBIT VS OCF VS FCFKRMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

KRMD's Return On Assets of -13.70% is in line compared to the rest of the industry. KRMD outperforms 58.15% of its industry peers.
KRMD has a Return On Equity of -22.55%. This is in the better half of the industry: KRMD outperforms 60.33% of its industry peers.
Industry RankSector Rank
ROA -13.7%
ROE -22.55%
ROIC N/A
ROA(3y)-30.34%
ROA(5y)-21.02%
ROE(3y)-43.74%
ROE(5y)-29.41%
ROIC(3y)N/A
ROIC(5y)N/A
KRMD Yearly ROA, ROE, ROICKRMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

The Gross Margin of KRMD (62.32%) is better than 63.59% of its industry peers.
In the last couple of years the Gross Margin of KRMD has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for KRMD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 62.32%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.65%
GM growth 5Y-0.23%
KRMD Yearly Profit, Operating, Gross MarginsKRMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

5

2. Health

2.1 Basic Checks

KRMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
KRMD has more shares outstanding than it did 1 year ago.
KRMD has more shares outstanding than it did 5 years ago.
KRMD has a better debt/assets ratio than last year.
KRMD Yearly Shares OutstandingKRMD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
KRMD Yearly Total Debt VS Total AssetsKRMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

An Altman-Z score of 15.69 indicates that KRMD is not in any danger for bankruptcy at the moment.
KRMD's Altman-Z score of 15.69 is amongst the best of the industry. KRMD outperforms 92.93% of its industry peers.
KRMD has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
KRMD has a better Debt to Equity ratio (0.03) than 69.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 15.69
ROIC/WACCN/A
WACC8.81%
KRMD Yearly LT Debt VS Equity VS FCFKRMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 2.48 indicates that KRMD has no problem at all paying its short term obligations.
KRMD has a Current ratio of 2.48. This is comparable to the rest of the industry: KRMD outperforms 51.09% of its industry peers.
A Quick Ratio of 1.92 indicates that KRMD should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.92, KRMD is in line with its industry, outperforming 51.09% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.48
Quick Ratio 1.92
KRMD Yearly Current Assets VS Current LiabilitesKRMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 30.00% over the past year.
Looking at the last year, KRMD shows a very strong growth in Revenue. The Revenue has grown by 22.12%.
KRMD shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.76% yearly.
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)22.12%
Revenue growth 3Y12.72%
Revenue growth 5Y7.76%
Sales Q2Q%27.18%

3.2 Future

The Earnings Per Share is expected to grow by 34.04% on average over the next years. This is a very strong growth
Based on estimates for the next years, KRMD will show a quite strong growth in Revenue. The Revenue will grow by 17.65% on average per year.
EPS Next Y28.6%
EPS Next 2Y34.77%
EPS Next 3Y34.04%
EPS Next 5YN/A
Revenue Next Year20.76%
Revenue Next 2Y19.69%
Revenue Next 3Y17.65%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
KRMD Yearly Revenue VS EstimatesKRMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
KRMD Yearly EPS VS EstimatesKRMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.05 -0.1 -0.15 -0.2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for KRMD. In the last year negative earnings were reported.
Also next year KRMD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KRMD Price Earnings VS Forward Price EarningsKRMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KRMD Per share dataKRMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

KRMD's earnings are expected to grow with 34.04% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.77%
EPS Next 3Y34.04%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for KRMD!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

KORU MEDICAL SYSTEMS INC

NASDAQ:KRMD (12/23/2025, 11:54:05 AM)

6.22

+0.15 (+2.47%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12 2025-11-12/amc
Earnings (Next)N/A N/A
Inst Owners56.97%
Inst Owner ChangeN/A
Ins Owners8.38%
Ins Owner Change1.57%
Market Cap288.11M
Revenue(TTM)39.07M
Net Income(TTM)-3.71M
Analysts80
Price Target5.76 (-7.4%)
Short Float %2.29%
Short Ratio6.96
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)64.99%
Min EPS beat(2)29.97%
Max EPS beat(2)100%
EPS beat(4)4
Avg EPS beat(4)39.61%
Min EPS beat(4)3.88%
Max EPS beat(4)100%
EPS beat(8)8
Avg EPS beat(8)38.65%
EPS beat(12)12
Avg EPS beat(12)33.06%
EPS beat(16)15
Avg EPS beat(16)30.05%
Revenue beat(2)2
Avg Revenue beat(2)5.58%
Min Revenue beat(2)5.51%
Max Revenue beat(2)5.66%
Revenue beat(4)3
Avg Revenue beat(4)3.78%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)6.5%
Revenue beat(8)7
Avg Revenue beat(8)4.72%
Revenue beat(12)7
Avg Revenue beat(12)1.12%
Revenue beat(16)11
Avg Revenue beat(16)2.1%
PT rev (1m)0%
PT rev (3m)0.89%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.17%
EPS NY rev (1m)12.5%
EPS NY rev (3m)9.68%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.12%
Revenue NY rev (1m)1.89%
Revenue NY rev (3m)1.89%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.37
P/FCF N/A
P/OCF 937.86
P/B 17.5
P/tB 18.25
EV/EBITDA N/A
EPS(TTM)-0.07
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0.01
OCFY0.11%
SpS0.84
BVpS0.36
TBVpS0.34
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -13.7%
ROE -22.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 62.32%
FCFM N/A
ROA(3y)-30.34%
ROA(5y)-21.02%
ROE(3y)-43.74%
ROE(5y)-29.41%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.65%
GM growth 5Y-0.23%
F-Score5
Asset Turnover1.44
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 57.64%
Cap/Sales 1.24%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.48
Quick Ratio 1.92
Altman-Z 15.69
F-Score5
WACC8.81%
ROIC/WACCN/A
Cap/Depr(3y)239.72%
Cap/Depr(5y)210.83%
Cap/Sales(3y)5.63%
Cap/Sales(5y)4.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y28.6%
EPS Next 2Y34.77%
EPS Next 3Y34.04%
EPS Next 5YN/A
Revenue 1Y (TTM)22.12%
Revenue growth 3Y12.72%
Revenue growth 5Y7.76%
Sales Q2Q%27.18%
Revenue Next Year20.76%
Revenue Next 2Y19.69%
Revenue Next 3Y17.65%
Revenue Next 5YN/A
EBIT growth 1Y43.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year104.66%
EBIT Next 3Y45.91%
EBIT Next 5YN/A
FCF growth 1Y96.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y106.61%
OCF growth 3YN/A
OCF growth 5YN/A

KORU MEDICAL SYSTEMS INC / KRMD FAQ

What is the ChartMill fundamental rating of KORU MEDICAL SYSTEMS INC (KRMD) stock?

ChartMill assigns a fundamental rating of 3 / 10 to KRMD.


What is the valuation status of KORU MEDICAL SYSTEMS INC (KRMD) stock?

ChartMill assigns a valuation rating of 1 / 10 to KORU MEDICAL SYSTEMS INC (KRMD). This can be considered as Overvalued.


Can you provide the profitability details for KORU MEDICAL SYSTEMS INC?

KORU MEDICAL SYSTEMS INC (KRMD) has a profitability rating of 2 / 10.


How financially healthy is KORU MEDICAL SYSTEMS INC?

The financial health rating of KORU MEDICAL SYSTEMS INC (KRMD) is 5 / 10.